• FirefoxUpgrade to the new Firefox »
  •  Dow Up1.31% Nasdaq Up0.98%

    Anacor Pharmaceuticals, Inc. (ANAC)

    -NasdaqGM
    38.56 Up 1.51(4.08%) 4:00PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue 3,955   2,931   4,158   8,485  
    Cost of Revenue202   -   -   -  
    Gross Profit 3,753   2,931   4,158   8,485  
    Operating Expenses
    Research Development19,521  19,261  15,935  12,796  
    Selling General and Administrative14,507  7,095  8,328  4,039  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (30,275) (23,425) (20,105) 134,150  
    Income from Continuing Operations
    Total Other Income/Expenses Net22  17  22  141,906  
    Earnings Before Interest And Taxes(30,253)(23,408)(20,083)132,175  
    Interest Expense1,089  1,100  1,089  1,102  
    Income Before Tax(31,342)(24,508)(21,172)131,073  
    Income Tax Expense -   -   -  1,706  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(31,342)(24,508)(21,172)129,367  
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (31,342) (24,508) (21,172) 130,748  
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (31,342) (24,508) (21,172) 130,748  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.